There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

As artificial intelligence rapidly gains prominence and sophistication, health care professionals in Rhode Island have been ...

At the Food Allergy Institute in Signal Hill, training the immune systems of patients to tolerate different forms of ...

A new service offering patients the opportunity to decide on their future care plans has been introduced in a hospital. The ...

A new meta-analysis adds to the body of literature promoting the benefits of exercise for patients with cancer.

Dr. Diamond’s Metacine adds a third and final product to the InstaFacial Collection, making its results even more impressive.

Together with a team of international clinical researchers, Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne have published the new global guideline for the ...

A new study of Australians living with chronic physical health conditions has found family members and doctors who dismiss their experiences cause ...

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Forms 8-K and other filings with the U.S. Securities and Exchange Commission. These documents are available at www.sec.gov.

Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...